Chemicals · NSE/BSE: TATVA
Tatva Chintan Pharma Chem Limited
Specialty Chemicals
Market Cap ₹0.03L Cr
Verdict: Average
Quality Scores
Multi-Bagger
68/100
Compounder Quality
55/100
Management Credibility
70/100
Governance
85/100
Cash Flow Quality
38/100
AI Summary
Tatva Chintan is a niche specialty chemical player with a strong global presence in Structure Directing Agents (SDA) and Phase Transfer Catalysts (PTC). While the company debuted with strong margins, recent years have seen a sharp compression due to inventory destocking in the global chemical sector and high energy costs. Despite revenue growth volatility, the company maintains a unique position as India's largest Glyme producer and the world's 2nd largest SDA manufacturer for zeolites. The business is currently in a transition phase, moving into Electrolyte Salts for supercapacitors and…
Top Opportunities
- 2nd largest manufacturer of SDAs for Zeolites globally
- India's largest Glyme producer and 3rd globally
- Diversified across PTC, SDA, and Electrolyte salts
Top Risks
- Negative Free Cash Flow for 9 consecutive years
- Sharp decline in ROE from 28% to 6%
- Operating margins highly volatile and currently suppressed
Latest report: Read the annual report summary →
Unlock the full report
Full sections, financial charts, AI chat and PDF export are available with Premium.